Vaxcyte, Inc.
US ˙ NasdaqGS ˙ US92243G1085

SecurityPCVX / Vaxcyte, Inc.
InstitutionFmr Llc
Latest Disclosed Ownership16,451,061 shares
Ownership 11.40%
Fmr Llc ownership in PCVX / Vaxcyte, Inc.

2026-05-06 - Fmr Llc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 16,451,061 shares of Vaxcyte, Inc. (US:PCVX). This represents 11.4 percent ownership of the company. In their previous filing dated 2025-09-08 , Fmr Llc had reported owning 13,132,825 shares, indicating an increase of 25.27 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2026-05-06 2026-05-06 13G/A 13,132,825 16,451,061 25.27 11.40 12.87
2025-09-08 2025-09-08 13G/A 12,104,049 13,132,825 8.50 10.10 7.45
2025-08-06 2025-08-06 13G/A 13,054,144 12,104,049 -7.28 9.40 -10.48
2025-02-12 2025-02-12 13G/A 15,746,667 13,054,144 -17.10 10.50 -18.21
2024-11-12 2024-11-12 13G/A 14,213,365 15,746,667 10.79 12.84 -14.06
2024-02-09 2024-02-09 13G/A 10,169,281 14,213,365 39.77 14.94 16.02
2023-02-09 2023-02-09 13G/A 7,874,350 10,169,281 29.14 12.88 -13.69
2022-02-09 2022-02-09 13G/A 7,642,405 7,874,350 3.03 14.92 -0.55
2021-02-08 2021-02-08 13G/A 5,670,048 7,642,405 34.79 15.00 34.20
2020-08-10 2020-08-10 13G 5,670,048 11.18

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VAXCYTE COM 92243G108 16,492,861 2,658,347 19.22 958,400 50.14 0.0100
2026-02-17 2025-12-31 13F VAXCYTE COM 92243G108 13,834,514 1,324,581 10.59 638,324 41.66 0.0325
2025-11-13 2025-09-30 13F VAXCYTE COM 92243G108 12,509,933 358,883 2.95 450,608 14.07 0.0234
2025-08-14 2025-06-30 13F VAXCYTE COM 92243G108 12,151,050 -361,184 -2.89 395,031 -16.39 0.0223
2025-05-12 2025-03-31 13F VAXCYTE COM 92243G108 12,512,234 -579,414 -4.43 472,462 -55.91 0.0302
2025-02-13 2024-12-31 13F VAXCYTE COM 92243G108 13,091,648 -2,709,019 -17.14 1,071,682 -40.64 0.0640
2024-11-13 2024-09-30 13F VAXCYTE COM 92243G108 15,800,667 -366,673 -2.27 1,805,542 47.90 0.1099
2024-08-13 2024-06-30 13F VAXCYTE COM 92243G108 16,167,340 -93,819 -0.58 1,220,796 9.90 0.0781
2024-05-13 2024-03-31 13F VAXCYTE COM 92243G108 16,261,159 2,047,794 14.41 1,110,800 24.45 0.0746
2024-02-13 2023-12-31 13F VAXCYTE COM 92243G108 14,213,365 136,328 0.97 892,599 24.38 0.0686
2023-11-13 2023-09-30 13F VAXCYTE COM 92243G108 14,077,037 20,801 0.15 717,647 2.23 0.0620
2023-08-11 2023-06-30 13F VAXCYTE COM 92243G108 14,056,236 2,247,671 19.03 701,968 58.61 0.0589
2023-08-11 2023-03-31 13F/A-1 VAXCYTE COM 92243G108 11,808,565 1,639,283 16.12 442,585 -9.24 0.0405
2023-05-11 2023-03-31 13F VAXCYTE COM 92243G108 11,808,565 1,639,283 442,585 0.0081
2023-02-13 2022-12-31 13F VAXCYTE COM 92243G108 10,169,282 1,272,085 14.30 487,617 128.36 0.0484
2022-11-10 2022-09-30 13F VAXCYTE COM 92243G108 8,897,197 383,791 4.51 213,533 15.27 0.0223
2022-08-12 2022-06-30 13F VAXCYTE COM 92243G108 8,513,406 136,464 1.63 185,253 -8.43 0.0185
2022-05-13 2022-03-31 13F VAXCYTE COM 92243G108 8,376,942 502,592 6.38 202,304 7.99 0.0162
2022-02-14 2021-12-31 13F VAXCYTE COM 92243G108 7,874,350 45,965 0.59 187,331 -5.68 0.0138
2022-02-14 2021-09-30 13F/A-1 VAXCYTE COM 92243G108 7,828,385 121,576 1.58 198,605 14.48 0.0158
2021-11-15 2021-09-30 13F VAXCYTE COM 92243G108 7,828,385 121,576 198,605 0.0157
2021-08-13 2021-06-30 13F VAXCYTE COM 92243G108 7,706,809 7,666 0.10 173,480 14.09 0.0136
2021-05-14 2021-03-31 13F VAXCYTE COM 92243G108 7,699,143 56,738 0.74 152,059 -25.12 0.0130
2021-02-08 2020-12-31 13F VAXCYTE COM 92243G108 7,642,405 1,266,642 19.87 203,058 -35.50 0.0181
2020-11-13 2020-09-30 13F VAXCYTE COM 92243G108 6,375,763 1,669,004 35.46 314,836 111.61 0.0318
2020-08-24 2020-06-30 13F/A-1 VAXCYTE COM 92243G108 4,706,759 4,706,759 148,780 0.0164
2020-08-13 2020-06-30 13F VAXCYTE COM 92243G108 4,706,759 148,780 0.0164
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.